Description
What RejuvaNAD+ Is and How It Works
RejuvaNAD+® is a sterile intravenous preparation of nicotinamide adenine dinucleotide (NAD+) designed for supervised infusion protocols. Teams integrate this IV formulation into structured infusion menus and wellness programs where consistent handling and labeling matter. Med Wholesale Supplies serves licensed clinics and healthcare professionals with authentic, brand-name medical products sourced through vetted distributors, with US distribution to support predictable lead times.
This preparation provides NAD+ in its oxidized form in an isotonic vehicle suitable for IV administration. It is preservative-free, produced under sterile conditions, and intended for direct infusion under professional oversight. Delivering NAD+ intravenously supports immediate systemic availability within monitored settings, enabling standardized workflows that align with your facility’s scope and policies.
Clinics often align this product with their in-house protocols for aseptic technique, line checks, and observation windows. The clear label format supports lot tracking and strength confirmation at chairside, which helps streamline intake and verification. For related therapy planning across service lines, see Pharmaceuticals or review best-practice guidance in Safety Protocols. If your team cross-trains in skin rejuvenation modules scheduled on different days, our overview on Mesotherapy Injections can help align expectations and room turnover timing.
Professional Applications
Clinics use RejuvaNAD+ within supervised infusion programs that emphasize cellular support, recovery services, and general wellness offerings. This product may appear in intensive reset days, or as a series spaced across broader lifestyle frameworks managed by your staff. Where appropriate, teams coordinate hydration, micronutrient add-ons, and adjunctive services on separate schedules, with nursing oversight and defined observation periods.
Facilities also map intake and consent workflows to match their practice model. Intake screening, vital checks, and chair assignment can be standardized to maintain consistent throughput. For device planning outside infusion, review How To Buy Cannulas to streamline procurement processes across departments. Some practices also sequence restorative procedures on different days, leveraging inventory that fits the same back-of-house routines.
Key Features
- Clinic-grade IV NAD+: sterile, preservative-free, isotonic
- Oxidized NAD+ form suitable for infusion programs
- GMP-compliant manufacturing with rigorous quality checks
- Consistent composition for standardized protocols
- Clear lot and expiration labeling for traceability
- Single-vial pack for straightforward inventory planning
- Pack strength reference: RejuvaNAD+ 500 mg
Benefits in Practice
Operational consistency helps teams run predictable schedules across rooms and providers. RejuvaNAD+ offers a standardized format that supports repeatable prep steps, which can shorten setup time and simplify staff training. Clear strength labeling aids quick verification at receipt and chairside, and the single-vial configuration makes inventory counts and rotation more direct. These characteristics help reduce variability during preparation and improve handoffs between nursing staff.
- Predictable setup: familiar, repeatable steps for IV prep
- Fewer variables: standardized composition and format
- Inventory clarity: single-vial configuration simplifies counts
- Traceability: lot and expiry data visible at a glance
- Scheduling ease: fits supervised wellness and recovery menus
- Team alignment: consistent handling across shift changes
Teams can adapt observation windows, line integrity checks, and discharge criteria according to internal policies. For broader training on sterile handling across service lines, see Safety Protocols. Clinics that schedule complementary services on separate days sometimes combine infusion programs with skin-focused modules; the overview on Mesotherapy Injections supports cross-training and role clarity across teams.
Composition & Ingredients
This product contains nicotinamide adenine dinucleotide (NAD+) in its oxidized form as the active component. Excipients include sterile water for injection and buffering agents. The formulation is preservative-free, isotonic, and developed for intravenous use in professional settings. Composition and excipients are selected to support stability and compatibility with standard IV administration practices under supervised conditions.
Packaging & Supply
Pack configuration: 500 mg x 1 vial. Many facilities favor this single-vial format for simplicity during receiving and stock rotation. The primary label includes lot and expiration information for traceability. When referencing internal inventories and par levels, use the exact pack description for clarity: RejuvaNAD+ 500 mg.
Clinics often barcode-scan incoming lots and rotate supply on a first-expiring, first-out basis. The straightforward pack size supports quick reconciliation between chair usage and inventory counts. Because labeling is clear and consistent, teams can confirm strength and lot data during both intake and pre-infusion checks, helping reduce avoidable delays within daily schedules.
Ordering & Logistics
Access is limited to licensed clinics and healthcare facilities with verified accounts. Sign in to view contract and volume tiers aligned to your purchasing plan. If you manage multi-site operations, you can set roles and approval thresholds to match your internal controls. Our team can also help consolidate similar items to simplify ordering windows and reduce vendor fragmentation.
Receiving workflows vary by facility. Many groups align delivery windows to match clinic hours, confirm labeling upon receipt, and stage stock in designated locations according to their SOPs. For procurement planning across service lines, the guide How To Buy Cannulas offers practical steps that translate well to infusion inventory routines. Practices that also run microinjection or device-based treatments sometimes coordinate ancillary items, such as MicronJet, on a separate schedule to keep infusion areas focused on IV care.
Comparable Products
Many clinics pair their infusion services with biostimulatory or regenerative injectables scheduled on different days. From our catalog, options include Nucleofill 20 and Croma PhilArt. These products serve different indications than an IV NAD+ preparation, yet practices often stock them together to maintain cohesive care pathways and a unified supply chain. Some facilities also explore exosome-focused adjuncts, such as ExoJuv, in separate appointments where appropriate.
Pricing & Access
Sign in to view current availability and contract options tailored for clinical procurement. Volume tiers may be available based on your ordering cadence and site count. Your contracted RejuvaNAD+ price can vary by volume, account verification, and program commitments. Multi-location groups may coordinate centralized purchasing or site-level access, depending on how formularies and service lines are managed.
Availability & Substitutions
Supply can vary based on production cycles and regional demand. If a temporary outage occurs, your account representative can discuss suitable alternatives from your approved formulary list. Confirm any substitution with your clinical leadership before scheduling sessions. Backorders, if present, are managed on a first-come basis at the time of allocation, and timelines may shift with upstream production changes.
Authoritative Sources
- NIH/NCBI PubChem: NAD+ Overview
- FDA: Sterile Drug Products – Manufacturing and Sterilization
- USP <797>: Pharmaceutical Compounding – Sterile Preparations
Ready to align your inventory to clinic schedules? Sign in to verify access and plan procurement with temperature-controlled handling when required and tracked US delivery.
Frequently Asked Questions
What clinical form and route does this product use?
This item is an intravenous preparation of NAD+ designed for supervised infusion in professional settings. It is a sterile, preservative-free, isotonic solution produced under GMP-compliant conditions. The oxidized form of NAD+ is provided for direct IV use. Clinics typically integrate it into structured infusion programs with their own intake, line checks, and observation windows according to internal procedures and professional judgment. It is not an oral capsule, tablet, or sublingual spray, and it is not intended for self-administration outside a clinical environment.
How do clinics integrate it into existing workflows?
Most facilities place this infusion within established wellness or recovery menus. Teams map the product to their intake, consent, and vitals checks, then schedule chair time alongside hydration or micronutrient protocols where appropriate. Some centers run concentrated reset days, while others space sessions across a broader plan. Many also align labeling checks, lot verification, and discharge criteria with their standard operating procedures to keep chair turnover predictable across shifts.
What handling and storage practices are typical?
Facilities follow their internal SOPs for receiving, labeling verification, and secure storage. Staff confirm lot and expiration data on receipt, stage vials in designated locations, and rotate stock using first-expiring, first-out principles. Before administration, clinicians confirm line integrity, infusion readiness, and observation plans. Refer to your institutional guidance and USP 797 for sterile handling principles. If your clinic coordinates other service lines, keep IV preparation areas distinct to maintain aseptic workflows.
Who can order and how is access verified?
Access is limited to licensed clinics and healthcare organizations. New accounts undergo credential verification, and multi-site groups can assign user roles and approvals to match purchasing policies. After verification, authorized users can sign in to review pack details, contract structures, and ordering windows. Many organizations set par levels and reorder triggers tied to clinic calendars to avoid supply gaps during high-demand blocks or special program days.
How is it different from oral or sublingual NAD+ products?
This preparation is formulated for intravenous administration in clinical settings. Oral capsules, tablets, or sublingual products are not the same class and are not interchangeable with a sterile IV solution. Clinics choose an IV formulation to support direct systemic availability under supervision and to standardize chairside workflows. Selection and scheduling should follow your professional judgment, institutional policies, and the service model used across relevant departments.
How are orders shipped and tracked?
Orders are processed for licensed accounts according to your delivery preferences and clinic hours. Tracking information is provided once items depart our facility. For clarity on cross-border or regional routing, your representative can advise timelines relative to clinic schedules. If you need documentation for incoming freight, let your team coordinate receiving windows in advance. For search visibility, some buyers reference RejuvaNAD+ US shipping when planning lead-time expectations and staffing coverage.
What influences contract tiers and budgeting?
Contracted terms can reflect order volume, cadence, and site count. Groups with multiple locations may consolidate purchasing to support consistent par levels and unified scheduling. Budget planning typically considers session volume, staffing, and chair availability across the program calendar. Your representative can outline contract options and ordering windows that align with your service lines. Pricing visibility is available after account verification, with tiering that supports clinical procurement workflows.
Specifications
- Main Ingredient:
- Manufacturer: Penmix Co., Ltd.
- Drug Class: Medical Device
- Generic Name: Nicotinamide adenine dinucleotide (NAD⁺)
- Package Contents: 500 mg x 1 Vial
- Storage Requirements: Room Temperature (2℃~25℃)
- Main Usage:
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
Powerfill®
Filorga® Art Filler® Universal with Lidocaine
Related Articles
Xeomin Clinical Guide For Safety, Units, And Brand Comparisons
Neuromodulator procurement is rarely just “pick a brand.” It touches patient expectations, adverse-event readiness, documentation,…
Merz Aesthetics Clinic Overview: Portals, Products, Access
Clinic teams often search for manufacturer resources when they are tightening procurement, training, and documentation.…
Sculptra vs Filler Guide for Clinical Planning and Workflow
Clinic teams often get pulled into “which is better” debates. In sculptra vs filler comparisons,…
Wholesale Fillers Sourcing Standards for Aesthetic Clinics
OverviewClinic purchasing teams face real risk when sourcing wholesale fillers. Product integrity, documentation quality, and…
Phosphatidylethanolamine Structure Practical Primer for Clinics
Membrane lipids show up in many clinical conversations. You may see them in lab reports,…
Aqualyx Clinical Overview and Practice Notes for Clinics
Injectable adipocytolysis (fat-cell disruption) sits between devices and surgery. It can also create avoidable risk…
Renefil Filler Clinic Guide To Natural-Looking Enhancement
In aesthetic practice, hyaluronic acid (HA) dermal fillers are often chosen for predictable handling, reversibility,…
Evenity vs Prolia: A Practical Clinic Comparison Guide
Choosing between bone-active injectables often comes down to risk profile, care setting, and follow-through. Evenity…

